To access this element change to forms mode OFF
Grant Award View - GA21642
Targeting Natural Killer Cells as Immunotherapy in Acute Myeloid...
GA ID:
GA21642
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
16-Jul-2018
Publish Date:
12-Sep-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2022
Value (AUD):
$458,911.08
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Early Career Fellowships
Grant Activity:
Targeting Natural Killer Cells as Immunotherapy in Acute Myeloid Leukaemia
Purpose:
Acute myeloid leukaemia (AML) is the most common acute leukaemia and is characterised by the outgrowth of mutated stem cells. Specialised immune cells called Natural Killer (NK) cells can detect and kill AML, however, this is not fool proof and AML remains a significant global health problem. This project aims to understand how AML affects NK cell functions, enabling the development of more targeted therapies that specifically enhance NK cell activity against AML.
GO ID:
GO Title:
NHMRC Early Career Fellowship for Funding 2019
Internal Reference ID:
GNT1158615
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED STATES